UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

Neurology, 2009-03, Vol.72 (9), p.800-805

2009

Volltextzugriff (PDF)

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Neurology, 2012-04, Vol.78 (17), p.1315-1322

2012

Volltextzugriff (PDF)

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

Neurology, 2011-02, Vol.76 (8), p.686-692

2011

Volltextzugriff (PDF)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Journal of neurology, neurosurgery and psychiatry, 2010-08, Vol.81 (8), p.907-912

2010

Volltextzugriff (PDF)

Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

BMC medical genomics, 2021-07, Vol.14 (1), p.183-15, Article 183

2021

Volltextzugriff (PDF)

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society

Neurology, 2012-02, Vol.78 (8), p.585-589

2012

Volltextzugriff (PDF)

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

Multiple sclerosis, 2009-10, Vol.15 (10), p.1175-1182

2009

Volltextzugriff (PDF)

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Neurology, 2002-01, Vol.58 (2), p.169

2002

Volltextzugriff (PDF)

Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2004-05, Vol.62 (9), p.1468-1481

2004

Volltextzugriff (PDF)

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2008-09, Vol.71 (10), p.766-773

2008

Volltextzugriff (PDF)

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Neurology, 2004-12, Vol.63 (11), p.2039-2045

2004

Volltextzugriff (PDF)

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2007-03, Vol.68 (13), p.977-984

2007

Volltextzugriff (PDF)

HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course

American journal of human genetics, 2003-03, Vol.72 (3), p.710-716

2003

Volltextzugriff (PDF)

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

Neurology, 2009-05, Vol.72 (20), p.1760-1765

2009

Volltextzugriff (PDF)

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2003-11, Vol.61 (10), p.1332-1338

2003

Volltextzugriff (PDF)

The epidemiology of multiple sclerosis: insights to a causal cascade

Handbook of clinical neurology, 2016, Vol.138, p.173-206

Goodin, D S

2016

Volltextzugriff (PDF)

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2003-09, Vol.61 (5), p.602-611

2003

Volltextzugriff (PDF)

Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

Neurology, 2000-07, Vol.55 (2), p.171-177

2000

Volltextzugriff (PDF)

The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 1999-06, Vol.52 (9), p.1737-1737

1999

Volltextzugriff (PDF)

Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

American journal of neuroradiology : AJNR, 2020-12, Vol.41 (12), p.2219-2226

2020

Volltextzugriff (PDF)

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496-1506

2002

Volltextzugriff (PDF)

Side effect profile of interferon beta-1b in MS: results of an open label trial

Neurology, 1996-02, Vol.46 (2), p.552

1996

Volltextzugriff (PDF)

Genotype-Phenotype Correlations in Multiple Sclerosis: "HLA" Genes Influence Disease Severity Inferred by [superscript 1]HMR Spectroscopy and MRI Measures

Brain (London, England : 1878), 2009-01, Vol.132 (1), p.250

2009

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS

Neurology, 2010-06, Vol.74 (23), p.1877-1885

2010

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(628)
Mit Volltextzugriff
(561)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(425)
Life Sciences & Biomedicine
(314)
Humans
(229)
Neurosciences & Neurology
(154)
Clinical Neurology
(134)
Male
(125)
Biological And Medical Sciences
(121)
Female
(117)
Adult
(103)
Middle Aged
(82)
Medical Sciences
(79)
Technology
(71)
Neurosciences
(67)
Physical Sciences
(65)
Neurology
(62)
Aged
(52)
Fundamental And Applied Biological Sciences. Psychology
(44)
Physics
(39)
Exact Sciences And Technology
(38)
Biochemistry & Molecular Biology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

The epidemiology of multiple sclerosis: insights to a causal cascade

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology

The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial

Side effect profile of interferon beta-1b in MS: results of an open label trial

Genotype-Phenotype Correlations in Multiple Sclerosis: "HLA" Genes Influence Disease Severity Inferred by [superscript 1]HMR Spectroscopy and MRI Measures

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS

Suchergebnisse filtern